These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18085675)

  • 21. The management and outcome of patients with germ-cell tumours treated in the Edinburgh Cancer Centre between 1988 and 2002.
    Howard GC; Conkey DS; Peoples S; McLaren DB; Hargreave TB; Tulloch DN; Walker W; Kerr GR
    Clin Oncol (R Coll Radiol); 2005 Sep; 17(6):435-40. PubMed ID: 16149287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of the International Germ Cell Consensus Classification to the Nova Scotia population of patients with germ cell tumours.
    Murphy EM; Douglas JA; Thompson K; Wood L
    Can Urol Assoc J; 2009 Apr; 3(2):120-4. PubMed ID: 19424465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of adolescent males with extracranial metastatic germ cell tumors: A report from the Malignant Germ Cell Tumor International Consortium.
    Shaikh F; Stark D; Fonseca A; Dang H; Xia C; Krailo M; Pashankar F; Rodriguez-Galindo C; Olson TA; Nicholson JC; Murray MJ; Amatruda JF; Billmire D; Stoneham S; Frazier AL
    Cancer; 2021 Jan; 127(2):193-202. PubMed ID: 33079404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laboratory markers and germ cell tumors.
    von Eyben FE
    Crit Rev Clin Lab Sci; 2003 Aug; 40(4):377-427. PubMed ID: 14582602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.
    J Clin Oncol; 1997 Feb; 15(2):594-603. PubMed ID: 9053482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: results of a multicentre study. Report from the Medical Research Council Working Party on Testicular Tumours.
    Lancet; 1985 Jan; 1(8419):8-11. PubMed ID: 2578205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum lactate dehydrogenase isoenzyme 1 and tumour volume are indicators of response to treatment and predictors of prognosis in metastatic testicular germ cell tumours.
    von Eyben FE; Blaabjerg O; Madsen EL; Petersen PH; Smith-Sivertsen C; Gullberg B
    Eur J Cancer; 1992; 28(2-3):410-5. PubMed ID: 1375486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Result of treatment for advanced germ cell tumor in the last decade].
    Ishioka J; Kageyama Y; Inoue M; Fukui N; Numao N; Saito K; Ichiyanagi N; Tanak M; Hyochi N; Fukuda H; Higashi Y
    Nihon Hinyokika Gakkai Zasshi; 2010 Mar; 101(3):539-46. PubMed ID: 20387513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?
    Spiess PE; Brown GA; Pisters LL; Liu P; Tu SM; Evans JG; Kamat AM; Black P; Tannir NM
    Cancer; 2006 Oct; 107(7):1503-10. PubMed ID: 16944534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of tumor marker decline as an independent prognostic factor in patients with relapsed metastatic germ-cell tumors.
    Mego M; Rejlekova K; Reckova M; Sycova-Mila Z; Obertova J; Rajec J; Mardiak J
    Neoplasma; 2009; 56(5):398-403. PubMed ID: 19580341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
    Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival of metastatic germ cell cancer patients assessed by international germ cell consensus classification in Japan.
    Shintaku I; Satoh M; Okajima E; Fujimoto H; Kamoto T; Ogawa O; Kawai K; Akaza H; Tsukamoto T; Naito S; Miki T; Arai Y
    Jpn J Clin Oncol; 2008 Apr; 38(4):281-7. PubMed ID: 18321891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germ cell tumours of testis: prognostic factors and results.
    Nikzas D; Champion AE; Fox M
    Eur Urol; 1990; 18(4):242-7. PubMed ID: 1705226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-orchiectomy tumor marker levels should not be used for International Germ Cell Consensus Classification (IGCCCG) risk group assignment.
    Fankhauser CD; Gerke TA; Roth L; Sander S; Grossmann NC; Kranzbühler B; Eberli D; Sulser T; Beyer J; Hermanns T
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):781-785. PubMed ID: 30637464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Body Mass Index and Outcomes in Germ-Cell Tumors.
    McGregor BA; Miller RE; O'Donnell E; Albiges LK; Sweeney CJ; Markt SC
    Clin Genitourin Cancer; 2019 Aug; 17(4):283-290. PubMed ID: 31129146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lactate dehydrogenase and its isoenzymes in testicular germ cell tumors: an overview.
    von Eyben FE
    Oncodev Biol Med; 1983; 4(6):395-414. PubMed ID: 6196755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
    Marwaha S; Venner PM; North SA
    Can J Urol; 2007 Oct; 14(5):3692-6. PubMed ID: 17949524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling.
    Kollmannsberger C; Nichols C; Meisner C; Mayer F; Kanz L; Bokemeyer C
    Ann Oncol; 2000 Sep; 11(9):1115-20. PubMed ID: 11061604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy.
    Mazumdar M; Bajorin DF; Bacik J; Higgins G; Motzer RJ; Bosl GJ
    J Clin Oncol; 2001 May; 19(9):2534-41. PubMed ID: 11331333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.